Riskpilot← Back to searchSign inGet full accessEmaljkliniken AB
ABActiveOrg 5569332868Emaljvägen 16Dental practice care activities · NACE 8623Est. 20139 employees
Revenue 2025
SEK 16,2M
+16% vs 2024
EBITDA margin
25.6%
+93% vs 2024
Equity ratio
87.9%
Financial strength
Net profit 2025
SEK 3,1M
+195% vs 2024
| Revenue | SEK 16,2M | +16% |
| EBITDA | SEK 4,2M | +93% |
| Net profit | SEK 3,1M | +195% |
| Total assets | SEK 11M | +9% |
| Equity | SEK 9,7M | +13% |
| Employees | 9 | — |
Legal name
Emaljkliniken AB
Org number
5569332868
Legal form
Aktiebolag
NACE code
8623 · Dental practice care activities
Founded
30 maj 2013
Share capital
SEK 50 000
Employees
9 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bedriva tandläkarklinik.
Address
Emaljvägen 16
Email
info@emaljkliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 13 683 | 16 782 | 15 549 | 13 960 | 16 245 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 300 | 4 962 | 3 990 | 2 150 | 4 155 |
| Depreciation & amort. | −145 | −145 | −908 | −944 | −1 175 |
| EBIT | 3 155 | 4 817 | 3 082 | 1 206 | 2 980 |
| Net financials | −1 | −1 | 19 | 101 | 105 |
| Profit before tax | 3 154 | 5 166 | 3 102 | 1 307 | 3 885 |
| Tax | −761 | −1 140 | −646 | −273 | −832 |
| Net profit | 2 393 | 4 026 | 2 456 | 1 034 | 3 053 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 234 | 7 743 | 9 161 | 10 132 | 11 042 |
| Equity | 2 668 | 5 065 | 7 521 | 8 555 | 9 709 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 416 | 1 878 | 839 | 776 | 1 333 |
| Total debt | 1 416 | 1 878 | 839 | 776 | 1 333 |
EBITDA margin
25.6%
This company
15.8%
Market median
+62% vs market
20212025
Equity ratio
87.9%
This company
38.2%
Market median
+130% vs market
20212025
Return on equity
31.4%
This company
18.4%
Market median
+71% vs market
20212025
Net profit margin
18.8%
This company
8.1%
Market median
+132% vs market
20212025
Asset turnover
1.47×
This company
1.12×
Market median
+31% vs market
20212025
Debt / equity
0.14×
This company
0.62×
Market median
+77% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
GR Audit | Audit | 2025 |
TK Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (2) | ||
AK Chief Executive Officer | Chief Executive Officer | 2022 – 2024 |
NK Audit | Audit | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Emaljkliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Amelin Khabout | Chief Executive Officer | 0 companies |
| George Rohyo | Audit | 0 companies |
| Tony Kristian Yakob | Chief Executive Officer | 0 companies |
| Niklas Kenneth Makal | Audit | 0 companies |
| Kerstin Elisabeth Quarnström | Deputy Board Member | 0 companies |
| Else Lisen Viviann Söderlind | Deputy Board Member | 0 companies |